|
Variable
|
Uni-variate analysis
|
Multi-variate analysis
|
|---|
|
OR (95% CI)
|
P-value
|
Adjusted OR (95% CI)
|
P-value
|
|---|
|
Male sex
|
0.842 (0.478–1.485)
|
0.553
|
0.718 (0.375–1.376)
|
0.319
|
|
Age
|
0.975 (0.958–0.993)
|
0.006
|
0.973 (0.949–0.998)
|
0.037
|
|
The path of laboratory test
| | | | |
|
Outpatients clinic
|
1.0 (Ref.)
| |
1.0 (Ref.)
| |
|
Hospitalization patients
|
2.204 (0.735–6.608)
|
0.158
|
2.459 (0.715–8.461)
|
0.154
|
|
Type of disease
| | | | |
|
UC
|
1.0 (Ref.)
| |
1.0 (Ref.)
| |
|
CD
|
3.810 (1.721–8.430)
|
0.001
|
2.492 (1.012–6.136)
|
0.047
|
|
Intestinal BD
|
2.778 (0.734–10.513)
|
0.132
|
1.356 (0.284–6.479)
|
0.703
|
|
Medications
| | | | |
|
5-ASA
|
0.381 (0.214–0.679)
|
0.001
|
0.548 (0.281–1.068)
|
0.077
|
|
Steroids
|
0.502 (0.132–1.914)
|
0.313
| | |
|
Azathioprine
|
1.784 (0.983–3.238)
|
0.057
| | |
|
Anti-TNF
|
1.584 (0.900–2.788)
|
0.111
| | |
|
Methotrexate
|
0.746 (0.340–1.637)
|
0.465
| | |
|
Othersa
|
0.295 (0.063–1.383)
|
0.121
| | |
|
Operation
|
2.041 (1.120–3.717)
|
0.020
|
2.714 (1.260–5.844)
|
0.011
|
|
Underlying disease
| | | | |
|
Hypertension
|
0.515 (0.053–5.037)
|
0.568
| | |
|
Osteoporosis
|
0.776 (0.371–1.624)
|
0.501
|
1.500 (0.699–3.217)
|
0.298
|
|
Othersb
|
1.131 (0.579–2.206)
|
0.719
|
2.459 (0.715–8.461)
|
0.154
|
- OR, odds ratio; CI, confidence interval; UC, Ulcerative colitis; CD, Crohn’s disease; BD, Behçet’s disease; 5-ASA, 5-aminosalicylic acid; anti-TNF, anti-tumor necrosis factor
- aMongersen, vedolizumab
- bMDS, SLE, AR, BOOP, OA, Osteoporosis, CAOD, cancer
